scispace - formally typeset
D

Domenica Zaino

Researcher at Academy for Urban School Leadership

Publications -  9
Citations -  355

Domenica Zaino is an academic researcher from Academy for Urban School Leadership. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 3, co-authored 6 publications receiving 231 citations.

Papers
More filters
Journal ArticleDOI

The Baffling Case of Ischemic Stroke Disappearance from the Casualty Department in the COVID-19 Era.

TL;DR: A study investigates the monthly variance of ischemic stroke using the ANOVA test and finds that it seems to have almost disappeared from the Casualty Department.
Journal ArticleDOI

Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients.

TL;DR: LDH and CRP should be considered a useful test for the early identification of patients who require closer respiratory monitoring and more aggressive supportive therapies to avoid poor prognosis.
Journal ArticleDOI

Stroke in COVID-19 patients-A case series from Italy.

TL;DR: The characteristics of 19 consecutive strokes occurring in COVID-19-positive patients, admitted from 21 February to 28 April at the Guglielmo da Saliceto Hospital in Piacenza, one of the outbreak epicenters in Italy, are described.
Journal ArticleDOI

Diagnostic Accuracy of a Bedside Screening Tool for Dysphagia (BSTD) in Acute Stroke Patients.

TL;DR: A user-friendly bedside examination to identify the risk of dysphagia in stroke patients at hospital admission had a 100% negative predictive value, indicating that this screening test is very useful in ruling out/confirming dysphagía in acute stroke patients.
Journal ArticleDOI

Multiple Sclerosis Treatment in the COVID-19 Era: A Risk-Benefit Approach

TL;DR: A multilevel strategy aimed at identifying the most appropriate vaccination schedule that is safe for people on disease-modifying drugs (DMDs) and a strict follow-up of high-risk people with multiple sclerosis to allow for the prompt administration of monoclonal antibodies to manage COVID-19 risks in this patient population is proposed.